Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 19:5:F1000 Faculty Rev-78.
doi: 10.12688/f1000research.6233.1. eCollection 2016.

Recent advances in understanding dengue

Sophie Yacoub  1 , Juthathip Mongkolsapaya  2 , Gavin Screaton  3
Affiliations
Review

Recent advances in understanding dengue

Sophie Yacoub et al. F1000Res. .

Abstract

Dengue is an emerging threat to billions of people worldwide. In the last 20 years, the incidence has increased four-fold and this trend appears to be continuing. Caused by one of four viral serotypes, dengue can present as a wide range of clinical phenotypes with the severe end of the spectrum being defined by a syndrome of capillary leak, coagulopathy, and organ impairment. The pathogenesis of severe disease is thought to be in part immune mediated, but the exact mechanisms remain to be defined. The current treatment of dengue relies on supportive measures with no licensed therapeutics available to date. There have been recent advances in our understanding of a number of areas of dengue research, of which the following will be discussed in this review: the drivers behind the global dengue pandemic, viral structure and epitope binding, risk factors for severe disease and its pathogenesis, as well as the findings of recent clinical trials including therapeutics and vaccines. We conclude with current and future dengue control measures and key areas for future research.

Keywords: Flavivirus; dengue; dengue virus.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare that they have no competing interests.

No competing interests were disclosed.

References

    1. Bhatt S, Gething PW, Brady OJ, et al. : The global distribution and burden of dengue. Nature. 2013;496(7446):504–7. 10.1038/nature12060 - DOI - PMC - PubMed
    1. WHO: Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Geneva: World Health Organization.2009. - PubMed
    1. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. : Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003;9(7):921–7. 10.1038/nm887 - DOI - PubMed
    1. Halstead SB: Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239(4839):476–81. - PubMed
    1. de Alwis R, Williams KL, Schmid MA, et al. : Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 2014;10(10):e1004386. 10.1371/journal.ppat.1004386 - DOI - PMC - PubMed

    2. F1000 Recommendation